✦ LIBER ✦

Efficacy of solifenacin in patients previously treated with tolterodine extended release 4 mg: Results of a 12-week, multicenter, open-label, flexible-dose study

✍ Scribed by Michael B. Chancellor; Norman Zinner; Kristene Whitmore; Kathleen Kobashi; Jeffrey A. Snyder; Paul Siami; Mickey Karram; Christine Laramée; James P. Capo' Jr.; Raafat Seifeldin; Sergio Forero-Schwanhaeuser; Indrani Nandy

Book ID: 116372227
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 171 KB
Volume: 30
Category: Article
ISSN: 0149-2918
DOI: 10.1016/j.clinthera.2008.10.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of a slow-release formulation o

Efficacy of a slow-release formulation of lanreotide (Autogel® 120 mg) in patients with acromegaly previously treated with octreotide long acting release (LAR): an open, multicentre longitudinal study

✍ C. L. Ronchi; M. Boschetti; E. C. Degli Uberti; S. Mariotti; S. Grottoli; P. Lol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 388 KB

Effects of fluvastatin extended-release

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: A 12-week, multicenter, randomized, open-label, parallel-group study

✍ Luis A. Alvarez-Sala; Victoria Cachofeiro; Luis Masana; Carmen Suarez; Blanca Pi 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Efficacy and tolerability of intravenous

Efficacy and tolerability of intravenous continuous erythropoietin receptor activator: A 19-week, phase ii, multicenter, randomized, open-label, dose-finding study with a 12-month extension phase in patients with chronic renal disease

✍ Anatole Besarab; Moro O. Salifu; N. Martin Lunde; Vinod Bansal; Steven Fishbane; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 1017 KB

Assessing symptom burden using the M. D.

Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia : Results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-α at a dose of 200 μg every 2 weeks

✍ Janice L. Gabrilove; Edith A. Perez; Dianne K. Tomita; Greg Rossi; Charles S. Cl 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 346 KB

## Abstract ## BACKGROUND. Patients with cancer who are receiving chemotherapy often experience chemotherapy‐induced anemia (CIA), which is associated with symptoms that reduce quality of life. The M. D. Anderson Symptom Inventory (MDASI) is a brief, self‐rating assessment scale that measures the

Efficacy and Safety Profile of Exenatide

Efficacy and Safety Profile of Exenatide Once Weekly Compared With Insulin Once Daily in Japanese Patients With Type 2 Diabetes Treated With Oral Antidiabetes Drug(s): Results From a 26-Week, Randomized, Open-Label, Parallel-Group, Multicenter, Noninferiority Study

✍ Inagaki, Nobuya; Atsumi, Yoshihito; Oura, Tomonori; Saito, Hitoshi; Imaoka, Take 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 962 KB